Antiapoptotic Function of Cdk9 (TAK/P-TEFb) in U937 Promonocytic Cells
Open Access
- 1 February 2001
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 75 (3) , 1220-1228
- https://doi.org/10.1128/jvi.75.3.1220-1228.2001
Abstract
Cdk9 is the catalytic subunit of TAK (cyclinT1/P-TEFb), a cellular protein kinase that mediates human immunodeficiency virus type 1 (HIV-1) Tat transcriptional activation function. To examine Cdk9 function in cells relevant to HIV-1 infection, we used a murine leukemia virus retrovirus vector to transduce and overexpress the cDNA of a dominant negative mutant Cdk9 protein (Cdk9-dn) in Jurkat T cells and U937 promonocytic cells. In Jurkat cells, overexpression of Cdk9-dn specifically inhibited Tat transactivation and HIV-1 replication but had no inhibitory effect on induction of CD69, CD25, and interleukin-2 following T-cell activation. In U937 cells, overexpression of Cdk9-dn sensitized cells to apoptosis, especially after phorbol myristate acetate (PMA) treatment to induce differentiation to macrophage-like cells. Because Cdk9 function is induced in PMA-treated U937 cells, Cdk9 may play an antiapoptotic role during monocyte differentiation.Keywords
This publication has 40 references indexed in Scilit:
- Tat Transactivation: A Model for the Regulation of Eukaryotic Transcriptional ElongationVirology, 1999
- HIV-1 Tat: coping with negative elongation factorsCurrent Opinion in Immunology, 1999
- Interferon γ Induces the Expression of p21waf-1 and Arrests Macrophage Cell Cycle, Preventing Induction of ApoptosisImmunity, 1999
- Cyclin T1 domains involved in complex formation with tat and TAR RNA are critical for tat-activationJournal of Molecular Biology, 1999
- Upregulation of cyclin T1/CDK9 complexes during T cell activationOncogene, 1998
- Immune Hyperactivation of HIV-1-Infected T Cells Mediated by Tat and the CD28 PathwayScience, 1997
- Control of RNA Polymerase II Elongation Potential by a Novel Carboxyl-terminal Domain KinaseJournal of Biological Chemistry, 1996
- The architecture of the interleukin-2 promoter: a reflection of T lymphocyte activationBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1995
- Direct interaction of human TFIID with the HIV-1 transactivator TatNature, 1994
- A 275 basepair fragment at the 5' end of the interleukin 2 gene enhances expression from a heterologous promoter in response to signals from the T cell antigen receptor.The Journal of Experimental Medicine, 1987